Developer docs
API playgroundTry for free, no card

Search company profiles

Gemeinschaftskrankenhaus Havelhöhe

Full company profile

uuid000sbzy

Namestring
Gemeinschaftskrankenhaus Havelhöhe
Legal namestring
Gemeinschaftskrankenhaus Havelhöhe gGmbH
Websiteurl
havelhoehe.de
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Gemeinschaftskrankenhaus Havelhöhe gGmbH is a non-profit acute-care hospital in Berlin-Kladow, founded on January 2, 1995 as Berlin's only anthroposophic hospital and operating under the legal form gemeinnützige GmbH. It runs 14 specialist departments and centres covering emergency medicine, anaesthesia, general/visceral and plastic surgery, gynaecology/obstetrics, gastroenterology and diabetology, geriatrics, integrative pain and addiction medicine, intensive care and cardiology, a lung centre, an oncology centre, psychosomatic medicine, and a day clinic for internal medicine. The hospital is an academic teaching hospital of Charité Universitätsmedizin Berlin and holds DKG certifications for its breast, colorectal and lung cancer centres, Germany's first ICLEZ-certified interventional lung emphysema centre, KTQ certification (5th recertification 2023), Baby-Friendly certification, and Europe's first ESR Green Radiology certificate.

Its clinical technology combines guideline-based conventional medicine with anthroposophic integrative therapies — including mistletoe therapy, metal colour light therapy, eurythmy, art and music therapy, anthroposophic nursing, and a regional organic nutritional concept. Distinctive technical capabilities include the Da Vinci Xi robotic surgery system (introduced January 2026), a specialised apheresis/immunotherapy centre, hyperthermia, free microvascular lymph node transplantation for lymphedema, and a Day Clinic for Internal Medicine that opened in February 2024. The affiliated Forschungsinstitut Havelhöhe (FIH) coordinates the multi-centre Network Oncology registry with over 24,000 oncological patients, producing real-world evidence studies including published outcomes on mistletoe therapy combined with immune checkpoint inhibitors for non-small cell lung cancer.

The hospital's business model is reimbursement-driven within Germany's regulated healthcare system. Inpatient acute services are billed under the G-DRG (Diagnosis-Related Groups) system to statutory health insurers (GKV), and private patients are reimbursed under GOÄ. The hospital also operates partial-hospitalisation (Tagesklinik) and outpatient specialty programmes billed under teilstationäre and ambulante codes, and participates in named quality contracts with Barmer and Techniker Krankenkasse for interdisciplinary multimodal pain therapy (IMST). GKH serves as a regional referral centre for Spandau and southwest Berlin, with physician-to-physician referral pathways, a 24/7 emergency department, community outreach through the Campus Havelhöhe events platform, and earned media coverage. Go-to-market combines enterprise-style referral relationships with primary care physicians and specialists, public-facing content via YouTube, Facebook and Instagram, and on-campus cultural and educational events.

Short descriptiontext

Gemeinschaftskrankenhaus Havelhöhe is a Berlin non-profit acute-care hospital combining conventional medicine with anthroposophic integrative therapies across 14 specialty departments. It serves patients in Berlin-Brandenburg, operates DKG-certified cancer centers, and functions as a Charité academic teaching hospital reimbursed under German G-DRG.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
acute hospital care, anthroposophic medicine, integrative oncology, medical specialist departments, hospital healthcare services
Industry2 codes
1Faith-Based & Nonprofit Hospital Systems
CodeHLAFAAAEPrimaryYes
2Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryNo
NAICS code2 codes
  • General Medical and Surgical Hospitals6221
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code2 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Acute Care Hospital Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Statutory Health Insurance (GKV) Reimbursement
TypeSubscription Recurring
Description

The hospital is a registered acute care provider reimbursed under Germany's statutory health insurance system. Treatment costs for covered services are billed through the German DRG (Diagnosis-Related Groups) system and other regulated fee schedules. The hospital participates in quality contracts with major insurers (Barmer, Techniker Krankenkasse) for specialized programs such as interdisciplinary multimodal pain therapy (IMST).

havelhoehe.de
2Private Health Insurance (PKV) Reimbursement
TypeSubscription Recurring
Description

The hospital treats private insurance patients who are reimbursed under private fee schedules (GOÄ - Gebührenordnung für Ärzte).

havelhoehe.de
3Day Clinic and Outpatient Services
TypeSubscription Recurring
Description

Partial hospitalization (Tagesklinik) programs for chronic diseases (COPD, IBD, chronic pain) and outpatient specialty clinics generate revenue under teilstationäre and ambulante billing codes.

havelhoehe.de
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Gemeinschaftskrankenhaus Havelhöhe is a non-profit acute hospital in Berlin-Kladow that delivers conventional evidence-based hospital medicine combined with anthroposophic integrative therapies. It operates 14 specialist departments and centers covering emergency medicine, surgery, internal medicine, oncology, obstetrics, geriatrics, pain and palliative medicine, and psychosomatics, functioning as an academic teaching hospital of Charité Universitätsmedizin Berlin.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Mistletoe therapy combined with checkpoint inhibitors showed median OS of 13.8 months vs 6.8 months for NSCLC patients
+5 more records
Product overview1 text field

Gemeinschaftskrankenhaus Havelhöhe is an acute hospital with an integrative approach combining conventional evidence-based medicine with anthroposophic therapies. The hospital operates as an academic teaching hospital of Charité and offers services through 14 specialist departments and centres. Core offerings include comprehensive acute hospital care (emergency medicine, surgery, internal medicine), while the distinctive integrative approach incorporates anthroposophic treatments such as mistletoe therapy, art therapies, music therapy, eurythmy, and specialized nursing care. The oncology centre is a key offering, comprising DKG-certified breast, colorectal, lung, and gynecological cancer centres. Supporting services include the Forschungsinstitut Havelhöhe (research institute), day clinic for internal medicine, integrative pain medicine, geriatrics, and comprehensive nutritional medicine programmes.

Product and service18 records
1Acute Hospital Care (14 specialist departments)
CategoryAcute Care Hospital Services
2Oncology Centre (Onkologisches Zentrum)
CategoryOncology Services
3Lung Centre (Lungenzentrum)
CategoryPulmonary Medicine
4Tagesklinik Innere Medizin (Day Clinic for Internal Medicine)
CategoryDay Clinic Programs
5Anaesthesia and Preclinical Emergency Medicine
CategoryAnaesthesia and Emergency Medicine
6General and Visceral Surgery with Da Vinci Xi Robotic Surgery
CategorySurgical Services
7Gynecology and Obstetrics
CategoryWomen's Health Services
8Gastroenterology, Diabetology and Nutritional Medicine
CategoryGastroenterology and Diabetology
9Geriatrics (Acute and Day Clinic)
CategoryGeriatric Services
10Integrative Pain Medicine
CategoryPain Medicine
11Intensive Care, Emergency Medicine and Cardiology
CategoryIntensive Care and Cardiology
12Interdisciplinary Addiction Medicine
CategoryAddiction Medicine
13Psychosomatic Medicine and Psychotherapy
CategoryPsychosomatic Medicine
14Centre for Immunotherapies / Apheresis Centre
CategoryImmunotherapy and Apheresis
15Anthroposophic Nursing Care
CategoryNursing Services
16Anthroposophic Therapies (Mistletoe Therapy, Eurythmy, Art and Music Therapy)
CategoryIntegrative Therapies
17Nutritional Therapy (Ernährungstherapie)
CategoryNutritional Medicine
18Plastic and Hand Surgery
CategoryPlastic Surgery
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-04
Description

A cooperation between GKH Havelhöhe and Klinikum Ernst von Bergmann in lung medicine, combining GKH's pneumology and interventional thoracic endoscopy with EvB's thoracic surgery, pneumology, and ventilation medicine. First collaboration involves joint thoracic surgery for lung cancer and emphysema treatment. GKH's ICLEZ-certified emphysema center is supported by EvB's thoracic surgery team. Both institutions aim to develop model structures for the future hospital landscape.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-01
Description

Dr. Maximilian Beck, specialist at Charité's Department of Gynecology, joined GKH as co-leader of the Gynecology and Obstetrics department alongside Dr. Jessica Groß. This represents an important step in medical cooperation between GKH and Charité's gynecology department, building on existing collaborations including the SHIP (Structural Heart Interventions Program) with Deutsche Herzzentrum Charité and the CCCTIM (Charité Competence Center for Traditional and Integrative Medicine).

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-02
Description

GKH Havelhöhe serves as a clinical trial site for Berlin Cures' Phase-II clinical study of BC 007 for Long COVID treatment. The study investigates the neutralization of functional autoantibodies (fAAKs) as a potential treatment for Long COVID. First results expected in early 2024.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-08-03
Description

GKH is a member of a coalition of ~30 free-profit and private Berlin hospitals advocating for equal financial treatment. The alliance, led by DRK Kliniken Berlin Köpenick, filed a lawsuit against the State of Berlin over unequal subsidy distribution favoring the publicly owned Vivantes hospital group.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-20
Description

GKH participates in a quality contract for interdisciplinary multimodal pain therapy (IMST) jointly developed by BARMER, Techniker Krankenkasse, and the Deutsche Schmerzgesellschaft e.V. This is one of 11 hospitals nationwide selected for this program, which offers more comprehensive and targeted therapy for chronic pain patients.

6Forschungsinstitut Havelhöhe (FIH)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Forschungsinstitut Havelhöhe (FIH) is the hospital's affiliated research institute conducting real-world evidence studies in integrative oncology. FIH coordinates the Network Oncology registry with over 24,000 patients. FIH researchers present at international congresses (ESMO, SIO Europe, WCTCIM) and publish in peer-reviewed journals.

havelhoehe.de
7Netzwerk Onkologie (Network Oncology)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multi-center clinical registry for integrative oncology, coordinated by FIH. Contains real-world data on over 24,000 oncological patients, supporting studies on mistletoe therapy, checkpoint inhibitors, and integrative cancer care outcomes. Partner institutions across Germany contribute data.

havelhoehe.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with CCCTIM on the OCEANIC systematic review on cost-effectiveness of integrative oncology, published in Frontiers in Public Health 2026. Both institutions co-authored the first comprehensive systematic review on health economic analyses in integrative oncology, aligned with the WHO Global Traditional Medicine Strategy 2025-2034.

9Galerie Gerda Bassenge
Strategic tierMinorTypeGTM or Marketing Partner
Description

Art gallery that provided auction support for the charitable art auction benefiting GKH Havelhöhe on July 4, 2026. David Bassenge served as auctioneer. Auction raised €11,100 for the hospital.

havelhoehe.de
Strategic tierMinorTypeGTM or Marketing Partner
Description

Local golf club that co-sponsored the charitable art auction benefiting GKH Havelhöhe on July 4, 2026, contributing to the €11,100 raised.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major German private hospital group with significant Berlin presence (including academic affiliations). Comparable as a broad multi-specialty hospital operator in the same German DRG context, lacking GKH's non-profit/anthroposophic niche.

TypeBroad incumbent
Description

German private hospital group owned by the non-profit Barmherzige Brüder Trier, providing broad multi-specialty inpatient care. Comparable as a German non-profit/private hospital operator with similar size profile to GKH, though without anthroposophic specialization.

TypeDirect peer
Description

Anthroposophic psychiatric and psychosomatic clinic in Buchenbach, Germany. Comparable as a fellow anthroposophic specialist hospital within the same movement, sharing GKH's psychosomatics and integrative therapy approach, though focused on psychiatry.

TypeBroad incumbent
Description

Europe's largest university hospital and GKH's academic teaching partner. Comparable as a Berlin acute-care hospital with overlapping oncology, gynecology, and cardiology services, but operating at far greater scale and without the anthroposophic focus.

TypeBroad incumbent
Description

Largest German private hospital group operating across all major acute specialties including oncology, cardiology, and surgery. Comparable as a multi-specialty German hospital operator, but as a for-profit chain without anthroposophic differentiation.

TypeRegional player
Description

Berlin's publicly-owned hospital network and the central party in the subsidy-discrimination lawsuit GKH supports. Comparable as a multi-site Berlin hospital operator competing for the same regional patient pool, but publicly owned and far larger.

TypeDirect peer
Description

Anthroposophic hospital in Arlesheim, Switzerland, offering integrated internal medicine, oncology, and psychiatry with anthroposophic therapies. Closest international peer sharing GKH's care model, anthroposophic pharmacy, and research orientation in integrative oncology.

TypeDirect peer
Description

Anthroposophic hospital in Bad Liebenzell, Germany, providing internal medicine, oncology, and psychosomatic care with anthroposophic therapies. Directly comparable as a German anthroposophic hospital operator with similar size and service mix.

TypeRegional player
Description

Public acute hospital in Potsdam, Brandenburg, and GKH's 2025 lung medicine cooperation partner. Comparable as a regional German acute hospital with overlapping pneumology, thoracic surgery, and oncology services, but state-owned and without anthroposophic focus.

10Filderklinik
TypeDirect peer
Description

Anthroposophic acute-care hospital in Filderstadt near Stuttgart operating on the same integrative medicine model as GKH Havelhöhe, combining conventional specialty care with anthroposophic therapies. Same legal structure, philosophy, and DKG-style certification ambitions, making it the closest German comparable.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gemeinschaftskrankenhaus Havelhöhe

Acute Care Hospital Serviceshavelhoehe.de

Gemeinschaftskrankenhaus Havelhöhe is a Berlin non-profit acute-care hospital combining conventional medicine with anthroposophic integrative therapies across 14 specialty departments. It serves patients in Berlin-Brandenburg, operates DKG-certified cancer centers, and functions as a Charité academic teaching hospital reimbursed under German G-DRG.

What Gemeinschaftskrankenhaus Havelhöhe does

Gemeinschaftskrankenhaus Havelhöhe gGmbH is a non-profit acute-care hospital in Berlin-Kladow, founded on January 2, 1995 as Berlin's only anthroposophic hospital and operating under the legal form gemeinnützige GmbH. It runs 14 specialist departments and centres covering emergency medicine, anaesthesia, general/visceral and plastic surgery, gynaecology/obstetrics, gastroenterology and diabetology, geriatrics, integrative pain and addiction medicine, intensive care and cardiology, a lung centre, an oncology centre, psychosomatic medicine, and a day clinic for internal medicine. The hospital is an academic teaching hospital of Charité Universitätsmedizin Berlin and holds DKG certifications for its breast, colorectal and lung cancer centres, Germany's first ICLEZ-certified interventional lung emphysema centre, KTQ certification (5th recertification 2023), Baby-Friendly certification, and Europe's first ESR Green Radiology certificate.

Its clinical technology combines guideline-based conventional medicine with anthroposophic integrative therapies — including mistletoe therapy, metal colour light therapy, eurythmy, art and music therapy, anthroposophic nursing, and a regional organic nutritional concept. Distinctive technical capabilities include the Da Vinci Xi robotic surgery system (introduced January 2026), a specialised apheresis/immunotherapy centre, hyperthermia, free microvascular lymph node transplantation for lymphedema, and a Day Clinic for Internal Medicine that opened in February 2024. The affiliated Forschungsinstitut Havelhöhe (FIH) coordinates the multi-centre Network Oncology registry with over 24,000 oncological patients, producing real-world evidence studies including published outcomes on mistletoe therapy combined with immune checkpoint inhibitors for non-small cell lung cancer.

The hospital's business model is reimbursement-driven within Germany's regulated healthcare system. Inpatient acute services are billed under the G-DRG (Diagnosis-Related Groups) system to statutory health insurers (GKV), and private patients are reimbursed under GOÄ. The hospital also operates partial-hospitalisation (Tagesklinik) and outpatient specialty programmes billed under teilstationäre and ambulante codes, and participates in named quality contracts with Barmer and Techniker Krankenkasse for interdisciplinary multimodal pain therapy (IMST). GKH serves as a regional referral centre for Spandau and southwest Berlin, with physician-to-physician referral pathways, a 24/7 emergency department, community outreach through the Campus Havelhöhe events platform, and earned media coverage. Go-to-market combines enterprise-style referral relationships with primary care physicians and specialists, public-facing content via YouTube, Facebook and Instagram, and on-campus cultural and educational events.

Gemeinschaftskrankenhaus Havelhöhe firmographics

Firmographics
Name
Gemeinschaftskrankenhaus Havelhöhe
Legal name
Gemeinschaftskrankenhaus Havelhöhe gGmbH
Website
https://havelhoehe.de
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Gemeinschaftskrankenhaus Havelhöhe is a Berlin non-profit acute-care hospital combining conventional medicine with anthroposophic integrative therapies across 14 specialty departments. It serves patients in Berlin-Brandenburg, operates DKG-certified cancer centers, and functions as a Charité academic teaching hospital reimbursed under German G-DRG.
Ownership category
akta.pro rank

Gemeinschaftskrankenhaus Havelhöhe industry classification

Industry
Product category
Acute Care Hospital Services
NAICS
General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Faith-Based & Nonprofit Hospital Systems (HLAFAAAE)
akta.pro secondary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

  • Acute hospital care
  • Anthroposophic medicine
  • Integrative oncology
  • Medical specialist departments
  • Hospital healthcare services

Where Gemeinschaftskrankenhaus Havelhöhe is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Gemeinschaftskrankenhaus Havelhöhe business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Statutory Health Insurance (GKV) Reimbursement: The hospital is a registered acute care provider reimbursed under Germany's statutory health insurance system. Treatment costs for covered services are billed through the German DRG (Diagnosis-Related Groups) system and other regulated fee schedules. The hospital participates in quality contracts with major insurers (Barmer, Techniker Krankenkasse) for specialized programs such as interdisciplinary multimodal pain therapy (IMST).
  2. Private Health Insurance (PKV) Reimbursement: The hospital treats private insurance patients who are reimbursed under private fee schedules (GOÄ - Gebührenordnung für Ärzte).
  3. Day Clinic and Outpatient Services: Partial hospitalization (Tagesklinik) programs for chronic diseases (COPD, IBD, chronic pain) and outpatient specialty clinics generate revenue under teilstationäre and ambulante billing codes.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Gemeinschaftskrankenhaus Havelhöhe product offering

Product offering

Core offering

Gemeinschaftskrankenhaus Havelhöhe is a non-profit acute hospital in Berlin-Kladow that delivers conventional evidence-based hospital medicine combined with anthroposophic integrative therapies. It operates 14 specialist departments and centers covering emergency medicine, surgery, internal medicine, oncology, obstetrics, geriatrics, pain and palliative medicine, and psychosomatics, functioning as an academic teaching hospital of Charité Universitätsmedizin Berlin.

Product overview

Gemeinschaftskrankenhaus Havelhöhe is an acute hospital with an integrative approach combining conventional evidence-based medicine with anthroposophic therapies. The hospital operates as an academic teaching hospital of Charité and offers services through 14 specialist departments and centres. Core offerings include comprehensive acute hospital care (emergency medicine, surgery, internal medicine), while the distinctive integrative approach incorporates anthroposophic treatments such as mistletoe therapy, art therapies, music therapy, eurythmy, and specialized nursing care. The oncology centre is a key offering, comprising DKG-certified breast, colorectal, lung, and gynecological cancer centres. Supporting services include the Forschungsinstitut Havelhöhe (research institute), day clinic for internal medicine, integrative pain medicine, geriatrics, and comprehensive nutritional medicine programmes.

Differentiator

Problem solved

Functional benefit

Products and services

  • Acute Hospital Care (14 specialist departments)
  • Oncology Centre (Onkologisches Zentrum)
  • Lung Centre (Lungenzentrum)
  • Tagesklinik Innere Medizin (Day Clinic for Internal Medicine)
  • Anaesthesia and Preclinical Emergency Medicine
  • General and Visceral Surgery with Da Vinci Xi Robotic Surgery
  • Gynecology and Obstetrics
  • Gastroenterology, Diabetology and Nutritional Medicine
  • Geriatrics (Acute and Day Clinic)
  • Integrative Pain Medicine
  • Intensive Care, Emergency Medicine and Cardiology
  • Interdisciplinary Addiction Medicine
  • Psychosomatic Medicine and Psychotherapy
  • Centre for Immunotherapies / Apheresis Centre
  • Anthroposophic Nursing Care
  • Anthroposophic Therapies (Mistletoe Therapy, Eurythmy, Art and Music Therapy)
  • Nutritional Therapy (Ernährungstherapie)
  • Plastic and Hand Surgery

Quantifiable outcome

  • Mistletoe therapy combined with checkpoint inhibitors showed median OS of 13.8 months vs 6.8 months for NSCLC patients
  • +5 more outcomes

Companies that use Gemeinschaftskrankenhaus Havelhöhe

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Gemeinschaftskrankenhaus Havelhöhe technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature6 records

Gemeinschaftskrankenhaus Havelhöhe partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Klinikum Ernst von Bergmann (Potsdam)coreStrategic or Co-development Partner · 4 June 2025A cooperation between GKH Havelhöhe and Klinikum Ernst von Bergmann in lung medicine, combining GKH's pneumology and interventional thoracic endoscopy with EvB's thoracic surgery, pneumology, and ventilation medicine. First collaboration involves joint thoracic surgery for lung cancer and emphysema treatment. GKH's ICLEZ-certified emphysema center is supported by EvB's thoracic surgery team. Both institutions aim to develop model structures for the future hospital landscape.
  • Charité Berlin – Frauenklinik (Department of Gynecology)coreStrategic or Co-development Partner · 1 June 2025Dr. Maximilian Beck, specialist at Charité's Department of Gynecology, joined GKH as co-leader of the Gynecology and Obstetrics department alongside Dr. Jessica Groß. This represents an important step in medical cooperation between GKH and Charité's gynecology department, building on existing collaborations including the SHIP (Structural Heart Interventions Program) with Deutsche Herzzentrum Charité and the CCCTIM (Charité Competence Center for Traditional and Integrative Medicine).
  • Berlin CuresminorStrategic or Co-development Partner · 2 January 2024GKH Havelhöhe serves as a clinical trial site for Berlin Cures' Phase-II clinical study of BC 007 for Long COVID treatment. The study investigates the neutralization of functional autoantibodies (fAAKs) as a potential treatment for Long COVID. First results expected in early 2024.
  • Clinic Alliance 'Ein gesundes Berlin – nicht ohne uns!'minorStrategic or Co-development Partner · 3 August 2023GKH is a member of a coalition of ~30 free-profit and private Berlin hospitals advocating for equal financial treatment. The alliance, led by DRK Kliniken Berlin Köpenick, filed a lawsuit against the State of Berlin over unequal subsidy distribution favoring the publicly owned Vivantes hospital group.
  • BARMER and Techniker KrankenkassecoreStrategic or Co-development Partner · 20 July 2023GKH participates in a quality contract for interdisciplinary multimodal pain therapy (IMST) jointly developed by BARMER, Techniker Krankenkasse, and the Deutsche Schmerzgesellschaft e.V. This is one of 11 hospitals nationwide selected for this program, which offers more comprehensive and targeted therapy for chronic pain patients.
  • Forschungsinstitut Havelhöhe (FIH)coreStrategic or Co-development PartnerThe Forschungsinstitut Havelhöhe (FIH) is the hospital's affiliated research institute conducting real-world evidence studies in integrative oncology. FIH coordinates the Network Oncology registry with over 24,000 patients. FIH researchers present at international congresses (ESMO, SIO Europe, WCTCIM) and publish in peer-reviewed journals.
  • Netzwerk Onkologie (Network Oncology)coreStrategic or Co-development PartnerMulti-center clinical registry for integrative oncology, coordinated by FIH. Contains real-world data on over 24,000 oncological patients, supporting studies on mistletoe therapy, checkpoint inhibitors, and integrative cancer care outcomes. Partner institutions across Germany contribute data.
  • Charité Competence Center for Traditional and Integrative Medicine (CCCTIM)coreStrategic or Co-development PartnerCollaboration with CCCTIM on the OCEANIC systematic review on cost-effectiveness of integrative oncology, published in Frontiers in Public Health 2026. Both institutions co-authored the first comprehensive systematic review on health economic analyses in integrative oncology, aligned with the WHO Global Traditional Medicine Strategy 2025-2034.
  • Galerie Gerda BassengeminorGTM or Marketing PartnerArt gallery that provided auction support for the charitable art auction benefiting GKH Havelhöhe on July 4, 2026. David Bassenge served as auctioneer. Auction raised €11,100 for the hospital.
  • Berliner Golf Club Gatow e. V.minorGTM or Marketing PartnerLocal golf club that co-sponsored the charitable art auction benefiting GKH Havelhöhe on July 4, 2026, contributing to the €11,100 raised.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Gemeinschaftskrankenhaus Havelhöhe competitors and assessment

Company assessment

Broad incumbents

  • Asklepios Kliniken: Major German private hospital group with significant Berlin presence (including academic affiliations). Comparable as a broad multi-specialty hospital operator in the same German DRG context, lacking GKH's non-profit/anthroposophic niche.
  • Sana Kliniken: German private hospital group owned by the non-profit Barmherzige Brüder Trier, providing broad multi-specialty inpatient care. Comparable as a German non-profit/private hospital operator with similar size profile to GKH, though without anthroposophic specialization.
  • Charité – Universitätsmedizin Berlin: Europe's largest university hospital and GKH's academic teaching partner. Comparable as a Berlin acute-care hospital with overlapping oncology, gynecology, and cardiology services, but operating at far greater scale and without the anthroposophic focus.
  • Helios Kliniken: Largest German private hospital group operating across all major acute specialties including oncology, cardiology, and surgery. Comparable as a multi-specialty German hospital operator, but as a for-profit chain without anthroposophic differentiation.

Direct peers

  • Friedrich-Husemann-Klinik: Anthroposophic psychiatric and psychosomatic clinic in Buchenbach, Germany. Comparable as a fellow anthroposophic specialist hospital within the same movement, sharing GKH's psychosomatics and integrative therapy approach, though focused on psychiatry.
  • Klinik Arlesheim: Anthroposophic hospital in Arlesheim, Switzerland, offering integrated internal medicine, oncology, and psychiatry with anthroposophic therapies. Closest international peer sharing GKH's care model, anthroposophic pharmacy, and research orientation in integrative oncology.
  • Paracelsus-Krankenhaus Unterlenhengardt: Anthroposophic hospital in Bad Liebenzell, Germany, providing internal medicine, oncology, and psychosomatic care with anthroposophic therapies. Directly comparable as a German anthroposophic hospital operator with similar size and service mix.
  • Filderklinik: Anthroposophic acute-care hospital in Filderstadt near Stuttgart operating on the same integrative medicine model as GKH Havelhöhe, combining conventional specialty care with anthroposophic therapies. Same legal structure, philosophy, and DKG-style certification ambitions, making it the closest German comparable.

Regional players

  • Vivantes Netzwerk für Gesundheit: Berlin's publicly-owned hospital network and the central party in the subsidy-discrimination lawsuit GKH supports. Comparable as a multi-site Berlin hospital operator competing for the same regional patient pool, but publicly owned and far larger.
  • Klinikum Ernst von Bergmann: Public acute hospital in Potsdam, Brandenburg, and GKH's 2025 lung medicine cooperation partner. Comparable as a regional German acute hospital with overlapping pneumology, thoracic surgery, and oncology services, but state-owned and without anthroposophic focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Gemeinschaftskrankenhaus Havelhöhe social profiles

Digital presence

Gemeinschaftskrankenhaus Havelhöhe compliance and trust

Trust signal

Compliance10 records

Gemeinschaftskrankenhaus Havelhöhe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gemeinschaftskrankenhaus Havelhöhe leadership team

Management profile

Number of profiles

Profiles16 records

Gemeinschaftskrankenhaus Havelhöhe subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Gemeinschaftskrankenhaus Havelhöhe funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gemeinschaftskrankenhaus Havelhöhe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gemeinschaftskrankenhaus Havelhöhe

What does Gemeinschaftskrankenhaus Havelhöhe do?

Gemeinschaftskrankenhaus Havelhöhe is a non-profit acute hospital in Berlin-Kladow that delivers conventional evidence-based hospital medicine combined with anthroposophic integrative therapies. It operates 14 specialist departments and centers covering emergency medicine, surgery, internal medicine, oncology, obstetrics, geriatrics, pain and palliative medicine, and psychosomatics, functioning as an academic teaching hospital of Charité Universitätsmedizin Berlin.

Is Gemeinschaftskrankenhaus Havelhöhe a public or private company?

Gemeinschaftskrankenhaus Havelhöhe is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Gemeinschaftskrankenhaus Havelhöhe founded?

Gemeinschaftskrankenhaus Havelhöhe was founded in 1995. It employs 501 to 1,000 people.

Where is Gemeinschaftskrankenhaus Havelhöhe based?

Gemeinschaftskrankenhaus Havelhöhe is headquartered in Berlin, Germany, in the Europe region.

How does Gemeinschaftskrankenhaus Havelhöhe make money?

Three revenue lines are on record. Statutory Health Insurance (GKV) Reimbursement is the primary driver. The others are private Health Insurance (PKV) Reimbursement and day Clinic and Outpatient Services.

Who are Gemeinschaftskrankenhaus Havelhöhe's main competitors?

Broad incumbents on record are Asklepios Kliniken, Sana Kliniken, Charité – Universitätsmedizin Berlin and Helios Kliniken. Direct peers are Friedrich-Husemann-Klinik, Klinik Arlesheim, Paracelsus-Krankenhaus Unterlenhengardt and Filderklinik. Regional players are Vivantes Netzwerk für Gesundheit and Klinikum Ernst von Bergmann.

Does Gemeinschaftskrankenhaus Havelhöhe have an API?

No public API is recorded for Gemeinschaftskrankenhaus Havelhöhe.

What industry is Gemeinschaftskrankenhaus Havelhöhe in?

Gemeinschaftskrankenhaus Havelhöhe's product category is Acute Care Hospital Services. Its primary akta.pro industry code is HLAFAAAE, Faith-Based & Nonprofit Hospital Systems, with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 6221 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales